Caliper Expects Q4 Revenues to Exceed Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – Caliper Life Sciences said today that based on a preliminary financial review it expects total revenues of $37.6 million for the fourth quarter of 2009, exceeding the company's revenue guidance of $33 to $35 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.